Next, we analyzed the TCGA-LIHC HCC cohort, which showed that patients with high ANGPTL8 expression had significantly worse overall survival (OS) and disease-free survival (DFS) than patients with low ANGPTL8 expression (Fig. S1C). The gene discussed is ANGPTL8; the disease is hepatocellular carcinoma.